title: Risperidone use and risk for gynecomastia in men.
authors.affiliation: Department of Pediatrics, Faculty of Medicine, University of British Columbia, Vancouver, Canada and Therapeutic Evaluation Unit, Child and Family Research Institute University of British Columbia, Vancouver, Canada metminan@popi.ubc.ca; metminan@shaw.ca Department of Family Medicine, Faculty of Medicine, University of British Columbia and Vancouver Coastal Health - Richmond, Vancouver, Canada Department of Pediatrics, Faculty of Medicine, University of British Columbia, Vancouver, Canada and Therapeutic Evaluation Unit, Child and Family Research Institute, University of British Columbia, Vancouver, Canada Department of Medicine, McGill University, Royal Victoria Hospital, Montreal, Canada.
authors.forename: Mahyar
authors.initials: M
authors.lastname: Etminan
authors.forename: Benji
authors.initials: B
authors.lastname: Heran
authors.forename: Bruce
authors.initials: B
authors.lastname: Carleton
authors.forename: James M
authors.initials: JM
authors.lastname: Brophy
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D014150:Antipsychotic Agents / Q000009:adverse effects*; D016022:Case-Control Studies; D016208:Databases, Factual; D006177:Gynecomastia / Q000139:chemically induced*; D006801:Humans; D008297:Male; D008875:Middle Aged; D012307:Risk Factors; D018967:Risperidone / Q000009:adverse effects*
chemical_list: D014150:Antipsychotic Agents; D018967:Risperidone